Catherine J. Frompovich, Guest
Waking Times
Something of pharmaceutical concern that the holistic/alternative medical community and the alternative press have been alleging for numerous years now, finally is being confirmed by a British Medical Journal paper published January 27, 2016.
Professor Peter C Gotzsche, MD, and several students published “Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports” after reviewing and including 76 trials with 64,381 pages of clinical study reports for 18,526 patients—certainly not a small sampling!
What the researchers concluded from their extensive retrospective study of pharmaceutical trials dealing with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) was that for children and adolescents, the risks for suicidality and aggression doubled. What are some of the pharmaceuticals involved? Antidepressants Prozac® and its knock off-type drugs: Celexa®, Lexapro®, Luvox®, Paxil®, and Zoloft®, plus Effexor®, Remeron®, Serzone®, and Wellbutrin®.
